全文获取类型
收费全文 | 19774篇 |
免费 | 1022篇 |
国内免费 | 459篇 |
专业分类
耳鼻咽喉 | 122篇 |
儿科学 | 342篇 |
妇产科学 | 297篇 |
基础医学 | 2472篇 |
口腔科学 | 507篇 |
临床医学 | 1431篇 |
内科学 | 2881篇 |
皮肤病学 | 151篇 |
神经病学 | 1269篇 |
特种医学 | 347篇 |
外科学 | 2331篇 |
综合类 | 3244篇 |
预防医学 | 1673篇 |
眼科学 | 70篇 |
药学 | 2867篇 |
6篇 | |
中国医学 | 668篇 |
肿瘤学 | 577篇 |
出版年
2023年 | 155篇 |
2022年 | 342篇 |
2021年 | 495篇 |
2020年 | 487篇 |
2019年 | 365篇 |
2018年 | 408篇 |
2017年 | 439篇 |
2016年 | 500篇 |
2015年 | 555篇 |
2014年 | 1192篇 |
2013年 | 1120篇 |
2012年 | 1042篇 |
2011年 | 1139篇 |
2010年 | 897篇 |
2009年 | 911篇 |
2008年 | 944篇 |
2007年 | 934篇 |
2006年 | 864篇 |
2005年 | 784篇 |
2004年 | 619篇 |
2003年 | 581篇 |
2002年 | 469篇 |
2001年 | 440篇 |
2000年 | 436篇 |
1999年 | 432篇 |
1998年 | 369篇 |
1997年 | 360篇 |
1996年 | 295篇 |
1995年 | 339篇 |
1994年 | 332篇 |
1993年 | 272篇 |
1992年 | 255篇 |
1991年 | 197篇 |
1990年 | 219篇 |
1989年 | 182篇 |
1988年 | 179篇 |
1987年 | 198篇 |
1986年 | 165篇 |
1985年 | 171篇 |
1984年 | 160篇 |
1983年 | 91篇 |
1982年 | 117篇 |
1981年 | 98篇 |
1980年 | 91篇 |
1979年 | 79篇 |
1978年 | 82篇 |
1977年 | 73篇 |
1976年 | 67篇 |
1975年 | 50篇 |
1973年 | 56篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
观察了神经降压素(NT)的肝细胞保护作用与Ca2+的关系。结果显示,醋氨酚使肝细胞Ca2+内流和肝脏钙含量增加,但对于线粒体Ca2+摄取及其钙含量无明显影响,表明细胞可能出现胞质Ca2+超载。若在醋氨酚之前给予NT则使肝细胞Ca2+内流明显减少,肝脏Ca2+含量有降低趋势,但线粒体钙含量显著增加。这些结果提示,NT通过减少Ca2+内流,增强线粒体贮存Ca2+的能力,部分缓解醋氨酚所致胞质Ca2+超载从而减轻细胞损伤。 相似文献
42.
43.
Neurotoxic effects of flunarizine (Fz), a selective calcium channel blocker, on the nigrostriatal dopamine system was investigated. Systemic injections of Fz to mice resulted in a transient loss of tyrosine hydroxylase (TH) immunoreactive nigrostriatal neurons without cell loss. TH immunoreactivity in these neurons was greatly reduced as rapidly as one day after drug administration (regardless of dosage used) and thereafter recovered in both dose- and time-dependent manners. Such a novel neurotoxic action of Fz may constitute a morphological substrate for reversible drug-induced parkinsonian signs described in recent clinical case reports. 相似文献
44.
Mnica De la Fuente Juan Jos Garrido Rosa María Arahuetes Angel Hernanz 《Journal of neuroimmunology》1993,42(1)
The neuropeptides neurotensin and neuromedin N (from 10−12 M to 10−9 M) have been showed in this study to stimulate significantly in vitro several steps of the phagocytic process: adherence to substrate, chemotaxis, ingestion of inert particles (latex beads) and production of superoxide anion measured by nitroblue tetrazolium reduction in resting peritoneal macrophages from BALB/c mice. A dose-response relationship was observed, with a maximal stimulation of the phagocytic process at 10−11 M. The two neuropeptides induced no change of intracellular cyclic AMP in murine macrophages. Moreover, adherence and chemotaxis decreased significantly in the presence of EGTA (1 mM), a chelator of extracellular Ca2+, or ryanodine (0.5 mM), a blocker of a Ca2+-gated channel from the endoplasmic reticulum, in both controls and samples with the addition of neurotensin or neuromedin N. These results suggest that there is no relation between the cAMP messenger system and the phagocytic process stimulation in murine peritoneal macrophages by neurotensin or neuromedin N. In addition, the results observed with EGTA and ryanodine could indicate that these two neuropeptides produce their effects through an increase of intracellular Ca2+ concentration. 相似文献
45.
Summary It has been suggested that urinary sialidase may play a role in the formation of renal stones. The present study was therefore undertaken to compare spectrophotometrically the different types of sialic acid concentrations and sialidase activities in fresh first morning urine specimens of men (21–65 years) with (13) and without (9) calcium oxalate renal stones. Although the free urinary sialic acid concentrations of the two groups of men were statistically about the same (P=0.0614), the total (P=0.003) and bound (P=0.0012) urinary sialic acid concentrations differed significantly. Both the total and bound sialic acid concentrations were lower in the urine specimens of the stone patients than in their healthy counterparts. This decrease in urinary sialic acid concentrations was firstly thought to be the result of elevated breakdown enzymes of sialic acid, which would favour the production of pyruvate. However, spectrophotometric determinations of the endogenous pyruvate concentrations of the two types of urine specimens did not differ significantly (P=0.0708). Secondly, the decrease in total urinary total sialic acid concentration of stone patients, could be attributed to less sialic acid synthesis or less renal excretion. Therefore, the same experiments were repeated using serum of 13 patients and 9 healthy men. Conversely, the total (P=0.4425) and bound (P=0.2850) serum sialic acid concentrations were found to be similar in the two types of subjects. However, the free serum sialic acid concentration of stone patients was significantly lower than in the healthy subjects (P=0.0062). This phenomenon is also reflected in the average ratio for serum free: bound sialic acid in healthy and stone patients, 1:7.9 and 1:18.7 respectively (P=0.0009). The lower free serum sialic acid concentration may lead to lower renal excretions of sialic acid. This may explain the decrease in total urinary sialic acid concentration in stone patients. The lower bound urinary sialic acid concentrations in patients was also reflected in the urinary free: bound sialic acid ratio for healthy (1:2.3) and stone patients (1:1.3). The difference between these two groups of men was highly significant (P=0.0001). This phenomenon might be explained by the urinary sialidase activities, which was spectrophotometrically determined at 334 nm at 37°C of 11 patients with stones and 17 healthy men. The ages of both groups of men were the same (P=0.326). An increase in urinary sialidase activity was observed with the stone patients (P=0.00001) when compared to specimens of healthy men. This might explain the decrease in urinary bound sialic acid concentration of the stone group. It seems from these results that the urinary concentration of sialic acid and the activity of urinary sialidase, may play a role in the pathogenesis of the multifactorial disease, urolithiasis. 相似文献
46.
Effects of different doses of alkaline citrate on urine composition and crystallization of calcium oxalate 总被引:1,自引:0,他引:1
Summary Prophylactic treatment with alkaline citrate in patients with recurrent calcium oxalate (CaOx) stone disease results in reduced CaOx supersaturation and increased urinary citrate. The effects of a single evening dose were compared with those of two and three daily doses in six recurrent CaOx stone formers with hypercalciuria, hypocitraturia or raised calcium/citrate quotients. While on a standardized hospital diet the patients were given 7.5 g (28 mmol) of sodium potassium citrate (URALYT-U) in one, two, and three doses. Fractional urine collections during 24 hours were analyzed for pH, composition, and crystallization risk (CR). All dosage regimens had favourable effects on urinary calcium, citrate, calcium/citrate quotients, and CaOx-CR. The most sustained effect was recorded with three divided doses. Single evening doses resulted in the most pronounced effects between 22.00–06.00 h, thereby counteracting the increased risk of CaOx crystallization during that period. In terms of 24 h urine composition the best effect was recorded with alkaline citrate administered three times daily, but because of the favourable response by a single evening dose between 22.00–06.00 h the assumption was made that this dosage regimen might be sufficient to reduce the risk of CaOx crystallization and stone formation. However, the validity of such an assumption can only be established by long-term clinical studies. 相似文献
47.
子宫肌瘤患者外周静脉与子宫静脉血管内皮细胞生长因子水平测定及临床意义 总被引:3,自引:0,他引:3
目的:探讨血管内皮细胞生长因子(VEGF)在子宫肌瘤发生和肌瘤生长中的作用。方法:手术中暴露子宫静脉后,抽取子宫静脉血3ml,同时抽取非输液肢体外周静脉血3ml。抽取配对正常妇女外周静脉血3ml。ELISA法测定VEGF水平。测量子宫重量、肌瘤总重量、肌瘤数目和最大肌瘤最大径线值。结果:子宫肌瘤患者子宫静脉血和外周静脉血VEGF水平分别为159.38±25.63pg/ml和76.35±26.61pg/ml,对照人群外周静脉血VEGF水平为42.53±29.47pg/ml。子宫静脉血中的VEGF水平明显高于外周静脉血(P=0.019),子宫肌瘤患者外周静脉血中的VEGF水平明显高于对照人群外周静脉血的VEGF水平(P=0.013)。子宫重量、肌瘤总重量、肌瘤数目、最大肌瘤最大径线都与子宫肌瘤患者子宫静脉和外周静脉VEGF呈显著正相关。结论:VEGF可能参与了子宫肌瘤的生长和病情发展。 相似文献
48.
目的探讨经体外反搏治疗的冠心病患者血清对血管内皮细胞基因表达的调控效应。方法分别取接受体外反搏治疗的冠心病患者1、24和36h时间点的血清,用于培养人脐静脉血管内皮细胞。用cDNA基因芯片检测3个治疗时点反搏前、后血管内皮细胞基因表达谱。结果反搏前后比较,有10个基因(核转录因子、真核转录启动因子-4、平滑肌的肌球蛋白重链、α2-肌动蛋白、微管蛋白β肽链、组织相容蛋白G、黑色素黏附分子、神经介素B受体、蛋白激酶4K2、血小板凝血酶敏感蛋白-1)的表达在3个治疗时点上出现显著改变。在1h点均为上调,在24h、36h时点均为下调。结论体外反搏治疗冠心病患者血清对血管内皮细胞的炎症反应、细胞凋亡相关基因表达有调效应,并随体外反搏治疗时间的增加早抑制其表达的趋势。 相似文献
49.
Antibodies against nerve growth factor (NGF) in sera were detected by enzyme-linked immunosorbent assays (ELISA), by their isolation after passage of sera through NGF immunoadsorbent columns and by their specificity to bind and immunoprecipitate mouse NGF as well as to stain by immunohistochemical methods cellular sites of NGF synthesis. Increased levels of anti-NGF antibodies were found in sera of herpes simplex virus (HSV)-infected patients but not in HSV-inoculated rabbits. As HSV latency is known to be promoted by NGF in vitro, these results may suggest that anti-NGF antibodies modulate the cytokine function of NGF and thus might play a role in HSV infection. The biological function of circulating antibodies against NGF, in general, is now open to future investigation. 相似文献
50.
目的探讨肝硬化患者血清中甲状腺素水平的变化与肝硬化病变程度及其临床实验室检查之间的相关性。方法用放免法测定肝硬化患者血清FT3、FT4、PC-Ⅲ、Ⅳ-C、LN及HA,并按Child—Pugh方法将肝功能分为A、B、C三级。结果随着肝硬化病变程度的加重,血清肝纤维化指标逐渐增高,甲状腺素呈下降趋势,同时血清甲状腺素水平与肝硬化的低蛋白血症、腹水及凝血酶原时间密切相关。结论肝硬化患者体内存在不同程度的甲状腺素水平紊乱,紊乱程度与肝功能受损程度有明显相关性,联合检测血清FT3、FT4、PC-Ⅲ、Ⅳ—C、LN及HA对估计肝硬化病变程度及判断预后有十分重要的临床价值。 相似文献